登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600373 证券简称：中文传媒公告编号：临2025-055 中文天地出版传媒集团股份有限公司 关于2025年度第一期超短期 融资券兑付完成的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 中文天地出版传媒集团股份有限公司（以下简称公司）于2025年1月3日在全国银行间债券市场公开发行 的2025年度第一期超短期融资券（债券简称：25中文天地SCP001，债券代码：012580028），发行总额 共计人民币10.00亿元，期限270天，发行年利率为1.69%，兑付日期为2025年9月30日（如遇法定节假日 或休息日，则顺延至其后的第一个工作日）。 具体内容详见公司于2025年1月8日披露在《中国证券报》《上海证券报》《证券日报》及上海证券交易 所网站（www.sse.com.cn）的《中文传媒2025年度第一期超短期融资券发行情况的公告》（公告编号： 临2025-002）。 近日，公司已完成2025年度第一期超短期融资券的兑付工作，本息兑付总额共计人民币1,01 ...

ZAWYA新闻网9月29日报道，阿布扎比投资局（ADIA）旗下全资子公司成为中国医疗健康领域私 募股权公司——礼来资本（GL Capital）单一资产延续基金（CV）的主投方。该基金投资的是美国制药 公司再鼎医药（SciClone Pharmaceuticals）。ADIA未披露此次投资金额，但据估计，该基金价值约2.3 亿美元。ADIA私募股权部执行董事哈马德·阿勒达赫里表示，再鼎是世界领先企业，其壮大得益于中国 医疗健康行业的长期稳定发展。早在2017年，礼来资本曾牵头以6.05亿美元完成对再鼎的私有化收购。 此次延续基金的设立，使礼来资本在继续掌控再鼎的同时，推动公司进一步拓展运营。 （原标题：阿布扎比投资局旗下公司成为礼来资本医疗健康基金主投方） ...

Group 1 - The company plans to divest 100% equity of Shanghai Clon to enhance focus on core business and improve asset operation efficiency [2][8][54] - The transaction involves the establishment of a special fund with a total planned fundraising of RMB 54.7 million, with contributions from various parties [9][24][36] - The estimated transfer price for the equity is up to RMB 125.6 million, based on the assessed value of the property held by Shanghai Clon [10][34] Group 2 - The company will continue to lease part of the property post-transfer, ensuring no significant impact on daily operations [11][54] - The proceeds from the transfer will be reinvested into the company's innovative drug business [12][54] - The transaction has been approved by the company's board and does not require shareholder approval [4][56] Group 3 - The special fund will primarily invest in the biopharmaceutical industry, focusing on acquiring assets such as industrial parks and factories [29][44] - The fund's management will be handled by Hongyi Tianjin, which is registered as a private fund manager [15][39] - The fund's operational period is set for five years, with potential extensions for orderly liquidation of investment projects [24][28]

复星医药(02196)公布，为进一步聚焦核心业务并提升资产运营效率，公司控股子公司复星医药产业拟 筹划转让上海克隆 100%股权(其主要资产为位于上海市徐汇区宜山路 1289 号的标的物业)。据此，2025 年 9 月 25 日，公司及控股子公司复星医药产业、上海复顺与弘毅天津、中汇人寿、弘元控股、弘赫洛 源共同签订《框架协议》;同日，复星医药产业还与弘毅天津、中汇人寿签订《合伙协议》。 2、于专项基金设立并满足约定条件后，由复星医药产业向专项基金或其控制实体转让所持有的上海克 隆 100%股权及对上海克隆享有的相应债权，该等转让对价合计不超过人民币12.56亿元。 上海克隆的主要资产为位于上海市徐汇区宜山路 1289 号的国有建设用地使用权及房屋所有权(即"标的 物业")。标的物业宗地面积为 19,944 平方米、建筑面积为 45,238.55 平方米，产权性质为工业用地。 本次转让完成后，该集团将不再直接持有上海克隆的股权，公司及部分控股子公司将于约定期间继续租 赁部分标的物业作为经营场所;此外，控股子公司上海复顺拟作为资产管理人为上海克隆提供标的资产 的运营管理服务。预计本次转让不会对集团的日常运营造成 ...

本次转让完成后，集团将不再直接持有上海克隆的股权，但仍将继续租赁部分标的物业作为经营场所， 预计本次转让不会对集团之日常运营造成重大影响。本次转让所得款项将用于集团创新药业务的持续投 入。 复星医药（600196）(600196.SH)发布公告，为进一步聚焦核心业务并提升资产运营效率，控股子公司 复星医药产业拟筹划转让上海克隆100%股权(其主要资产为位于上海市徐汇区宜山路1289号的标的物 业)，本次交易步骤及结构如下：1、控股子公司复星医药产业拟作为LP现金出资人民币5460万元与弘毅 天津、中汇人寿共同出资设立专项基金(即本次投资)，预计持有该基金足额募集后9.98%的财产份 额;2、于专项基金设立并满足约定条件后，控股子公司复星医药产业拟以不超过人民币12.56亿元向专 项基金或其控制的实体转让所持有的上海克隆100%的股权和对上海克隆享有的债权(即本次转让)。 ...

本次转让完成后，集团将不再直接持有上海克隆的股权，但仍将继续租赁部分标的物业作为经营场所， 预计本次转让不会对集团之日常运营造成重大影响。本次转让所得款项将用于集团创新药业务的持续投 入。 智通财经APP讯，复星医药(600196.SH)发布公告，为进一步聚焦核心业务并提升资产运营效率，控股 子公司复星医药产业拟筹划转让上海克隆100%股权(其主要资产为位于上海市徐汇区宜山路1289号的标 的物业)，本次交易步骤及结构如下：1、控股子公司复星医药产业拟作为LP现金出资人民币5460万元与 弘毅天津、中汇人寿共同出资设立专项基金(即本次投资)，预计持有该基金足额募集后9.98%的财产份 额;2、于专项基金设立并满足约定条件后，控股子公司复星医药产业拟以不超过人民币12.56亿元向专 项基金或其控制的实体转让所持有的上海克隆100%的股权和对上海克隆享有的债权(即本次转让)。 ...

每经AI快讯，9月26日，复星医药（600196）(600196.SH)公告称，控股子公司复星医药产业拟筹划转让 上海克隆100%股权。复星医药产业拟作为LP出资5460万元与弘毅天津、中汇人寿共同设立专项基金， 预计持有该基金9.98%的财产份额。专项基金设立后，复星医药产业拟以不超过12.56亿元向专项基金或 其控制实体转让所持上海克隆100%股权和对上海克隆享有的债权。转让所得款项将用于创新药业务的 持续投入。 ...

ConversationI would now like to hand the conference over to the CEO of 3i Group, Simon Borrows, to open the presentation. Please go ahead.Good day, and thank you for standing by. [Operator Instructions] Welcome to the 3i Group plc Capital Markets Seminar. [Operator Instructions] Please be advised that today's conference is being recorded.Simon BorrowsCEO & Executive Director Good morning, and welcome to our 3i Capital Markets Seminar. I'm Simon Borrows, Chief Executive of 3i. I'm joined today by James Hatch ...

Portfolio Performance - Private Equity and Infrastructure portfolios are performing resiliently despite a subdued macroeconomic environment[6] - Royal Sanders continues to perform well, and the broader PE portfolio shows improving momentum[6] - MAIT's sale was announced earlier this month, with total gross proceeds of approximately £143 million, a roughly 30% increase over its valuation on March 31, 2025, resulting in a 2.7x MM and approximately 27% IRR[6] - Action's year-to-date sales (as of September 21, 2025) reached €10.9 billion, which is 18% higher than the same period last year[6] - Action's year-to-date like-for-like (LFL) sales growth is 6.5% (compared to 6.8% at the end of August 2025), driven by transaction growth in all countries[6] - Action's operating EBITDA for the 12 months leading up to the end of P9 2025 is expected to be approximately €2,295 million, a 21% increase from €1,894 million at the end of P9 2024[6] Action Expansion - Action added 207 net new stores year-to-date and is on track to deliver or exceed 370 net new stores in 2025[6] - Action opened 7 stores in Switzerland year-to-date, and its first store in Romania opened on September 24, 2025[6] Investment and Acquisition - On September 24, 2025, 3i entered into an agreement with GIC to purchase a limited partnership interest representing 2.2% of Action equity in exchange for the issue of 19,916,225 new ordinary shares in 3i Group plc[6] - 3i invested approximately €1.7 billion in consumer businesses over the last 2 years[11] - 3i invested £124 million in MPM[18] - 3i invested approximately €145 million in WaterWipes[49] - 3i invested approximately £53 million in MAIT[95] - 3i invested £99 million in OMS[111] MPM Transaction - The total gross proceeds from the MPM transaction are approximately £400 million, with a money multiple of 3.2x and an IRR of 29%[44]

Group 1 - Hongta Securities is publicly recruiting four senior executives, indicating an intensifying competition for talent in the securities industry [2] - The recruitment includes positions such as Vice President, Chief Information Officer, and Secretary of the Board, with specific requirements for candidates [2] - This trend of market-oriented talent selection among securities firms is expected to enhance corporate governance and decision-making efficiency, injecting new momentum into stock prices [2] Group 2 - Zhejiang Securities has established a new equity investment fund with a capital contribution of 2 billion yuan, reflecting a strategic move into the private equity sector [3] - This initiative aims to diversify Zhejiang Securities' profitability and strengthen its competitiveness in investment management [3] - The establishment of such funds may encourage more institutions to engage in equity investment, promoting industry transformation and supporting the real economy [3] Group 3 - Frequent turnover of fund managers is observed, with several managers resigning from their positions, indicating accelerated talent mobility within the industry [4] - The new fund managers generally have less experience, which may impact the stability of the funds they manage [4] - Changes in management of underperforming funds in sectors like pharmaceuticals and Hong Kong stocks could increase volatility in these markets [4] Group 4 - The stock private equity position index has risen to 78.04%, marking a significant increase in investor confidence among professional investors [5] - Billion-yuan private equity firms are showing the largest increase in positions, suggesting a positive outlook for the market [5] - This rise in positions is likely to enhance market risk appetite and support heavyweight stocks, potentially attracting more incremental capital into the market [5]